Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 7;20(2):2.
doi: 10.1007/s11910-020-1023-y.

Neurological Complications of Measles (Rubeola)

Affiliations
Review

Neurological Complications of Measles (Rubeola)

Marc C Patterson. Curr Neurol Neurosci Rep. .

Abstract

Purpose of review: Owing to vaccine hesitancy, there has been a resurgence of measles infections in developed countries. Practitioners can expect to see an increase in patients with neurologic complications of measles. These devastating disorders include primary measles encephalitis, acute post measles encephalitis, subacute sclerosing panencephalitis (SSPE), and measles inclusion body encephalitis (MIBE).

Recent findings: Although there are many unanswered questions regarding the neurologic complications of measles, recent advances have led to better understanding of the mechanism of the spread of measles within the nervous system, particularly the disruption of F protein function, which raises the possibility of treatment with fusion-inhibiting molecules. Measles and its neurological complications are preventable and must be prevented. Neurologists must educate other clinicians and the public regarding the consequences of inadequate herd immunity to measles. More effective treatments for SSPE and MIBE may be available in the near future, but currently these remain lethal diseases.

Keywords: Acute post-measles encephalitis; MIBE; Measles immunization; Primary measles encephalitis; SSPE; Vaccine hesitancy.

PubMed Disclaimer

References

    1. Am J Trop Med Hyg. 2019 Jul;101(1):260-262 - PubMed
    1. Ann Neurol. 1984 Apr;15(4):353-60 - PubMed
    1. Lancet. 2001 Jan 27;357(9252):299-301 - PubMed
    1. Neurology. 2004 Oct 26;63(8):1352-3 - PubMed
    1. Brain Dev. 1993 Sep-Oct;15(5):346-55 - PubMed

MeSH terms

Substances

LinkOut - more resources